Tolerability of carboplatin, paclitaxel and erlotinib as first-line treatment of ovarian cancer Article

Blank, SV, Curtin, JP, Goldman, NA et al. (2005). Tolerability of carboplatin, paclitaxel and erlotinib as first-line treatment of ovarian cancer . JOURNAL OF CLINICAL ONCOLOGY, 23(16_suppl), 5052-5052. 10.1200/jco.2005.23.16_suppl.5052

cited authors

  • Blank, SV; Curtin, JP; Goldman, NA; Fusco, E; Lesko, Z; Hochster, H; Runowicz, CD; Wadler, S; Muggia, FM

authors

publication date

  • June 1, 2005

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 5052

end page

  • 5052

volume

  • 23

issue

  • 16_suppl